Melioidosis, also known as Whitmore disease, is an infectious disease caused by the bacterium Burkholderia pseudomallei. It is predominantly seen in tropical climates in Southeast Asia and Northern Australia, where it is transmitted via contact with contaminated water or soil. The clinical course of Melioidosis can vary greatly, ranging from asymptomatic disease to acute or chronic infection. In some cases, there is a latency period after initial infection, followed by reactivation. Symptomatic disease manifests with localized symptoms, pulmonary symptoms, or disseminated systemic symptoms. Antimicrobial therapy is the mainstay of treatment; in severe cases, adjunct therapy is also required. There are no vaccinations available against B. pseudomallei; prevention involves avoiding potentially contaminated sources, wearing protective gear in environments where there is a risk of contracting the pathogen, and observing general contact measures when interacting with infected patients (e.g., gloves, gowns).
- Distribution: occurs in tropical climates, mainly in Southeast Asia (e.g., Thailand, Malaysia) and Northern Australia
- Incidence: ∼ 150,000 case/year worldwide, with most cases occurring in wet seasons
Epidemiological data refers to the US, unless otherwise specified.
Pathogen: Burkholderia pseudomallei
- Facultative intracellular gram-negative bacterium
- Risk factors
- Incubation period: 1–21 days (mean ∼ 9 days)
- Most cases are subclinical or asymptomatic.
- Symptomatic cases can be acute, chronic (> 2 months), or reactivations of latent infection.
- Clinical features depend on the infected organ:
- Acute pulmonary infection (most common): wide range of presentations (mild to severe)
- Localized infection: skin ulcer, nodule, or abscess
- Visceral abscesses: especially in the prostate, spleen, kidney, and liver
- Disseminated infection: occurs in ∼ 55% of cases and has a 20% mortality rate. Manifests with fever and septic shock.
The differential diagnoses listed here are not exhaustive.